Search Results - Leitermann, Kate

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease

    First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease by Ferrero, James, Williams, Leslie, Stella, Heather, Leitermann, Kate, Mikulskis, Alvydas, O'Gorman, John, Sevigny, Jeff

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: